Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL9643 in Dry Eye Disease
NCT04268069Phase 2Completed
- Start
- Feb 2020
- Primary completion
- Oct 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PL9643 in dry eye disease (DED). Started Feb 2020; status: completed.
02
Drugs
PL9643
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04268069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04268069.